DE2013039A1 - Arzneimitteltablette zur oralen Verabreichung - Google Patents
Arzneimitteltablette zur oralen VerabreichungInfo
- Publication number
- DE2013039A1 DE2013039A1 DE19702013039 DE2013039A DE2013039A1 DE 2013039 A1 DE2013039 A1 DE 2013039A1 DE 19702013039 DE19702013039 DE 19702013039 DE 2013039 A DE2013039 A DE 2013039A DE 2013039 A1 DE2013039 A1 DE 2013039A1
- Authority
- DE
- Germany
- Prior art keywords
- tablet according
- compound
- water
- citrate
- tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB04670/69A GB1291281A (en) | 1969-03-20 | 1969-03-20 | Improvements in pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2013039A1 true DE2013039A1 (de) | 1970-09-24 |
Family
ID=10045462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19702013039 Pending DE2013039A1 (de) | 1969-03-20 | 1970-03-19 | Arzneimitteltablette zur oralen Verabreichung |
Country Status (10)
Country | Link |
---|---|
BE (1) | BE747656A (fr) |
DE (1) | DE2013039A1 (fr) |
DK (1) | DK128674B (fr) |
ES (1) | ES377725A1 (fr) |
FI (1) | FI51653C (fr) |
FR (1) | FR2035118B1 (fr) |
GB (1) | GB1291281A (fr) |
IL (1) | IL34089A (fr) |
NL (1) | NL143419B (fr) |
SE (1) | SE379284B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2083622B1 (fr) * | 1970-03-27 | 1975-08-22 | Sankyo Co | |
US3969524A (en) * | 1974-08-13 | 1976-07-13 | Hoffmann-La Roche Inc. | Stable amoxicillin dosage form |
JPS5329936A (en) * | 1976-08-31 | 1978-03-20 | Takeda Chem Ind Ltd | Antibiotic composition |
EP0012495B1 (fr) * | 1978-12-08 | 1983-06-22 | Beecham Group Plc | Composition pharmaceutique comprenant un sel hydrosoluble d'amoxycilline et polyvinylpyrrolidone, et une ampoule contenant une dose unitaire de cette composition |
CA2061520C (fr) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Systeme de delivrance accelerant l'effet et accroissant la puissance |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2438106A (en) * | 1944-06-09 | 1948-03-23 | Wyeth Corp | Peroral penicillin compositions |
US2864744A (en) * | 1955-09-02 | 1958-12-16 | American Home Prod | Penicillin in solid dosage unit form |
US3131123A (en) * | 1959-03-13 | 1964-04-28 | Lab Francais De Therapeutique | Enteric tablets and manufacture thereof |
GB1276839A (en) * | 1968-08-02 | 1972-06-07 | Sandoz Products Ltd | Antibiotic compositions |
-
1969
- 1969-03-20 GB GB04670/69A patent/GB1291281A/en not_active Expired
-
1970
- 1970-03-16 IL IL34089A patent/IL34089A/xx unknown
- 1970-03-19 DK DK138070AA patent/DK128674B/da not_active IP Right Cessation
- 1970-03-19 BE BE747656D patent/BE747656A/fr not_active IP Right Cessation
- 1970-03-19 FI FI700775A patent/FI51653C/fi active
- 1970-03-19 DE DE19702013039 patent/DE2013039A1/de active Pending
- 1970-03-20 SE SE7003870A patent/SE379284B/xx unknown
- 1970-03-20 ES ES377725A patent/ES377725A1/es not_active Expired
- 1970-03-20 FR FR7010069A patent/FR2035118B1/fr not_active Expired
- 1970-03-20 NL NL707004004A patent/NL143419B/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2035118B1 (fr) | 1974-08-30 |
FI51653B (fr) | 1976-11-30 |
FI51653C (fi) | 1977-03-10 |
NL7004004A (fr) | 1970-09-22 |
ES377725A1 (es) | 1972-10-16 |
IL34089A0 (en) | 1970-05-21 |
BE747656A (fr) | 1970-09-21 |
SE379284B (fr) | 1975-10-06 |
GB1291281A (en) | 1972-10-04 |
IL34089A (en) | 1974-05-16 |
FR2035118A1 (fr) | 1970-12-18 |
NL143419B (nl) | 1974-10-15 |
DK128674B (da) | 1974-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69109021T2 (de) | Augentropfenarzneimittel. | |
DE69319480T2 (de) | Badepräparat | |
EP0178436A1 (fr) | Capsules de gélatine souple contenant de l'ibuprofen et leur procédé de préparation | |
AT393221B (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken | |
DE60107272T2 (de) | Eisenverbindungen | |
DE69427981T2 (de) | Verkapselter arzneistoff | |
DE3314150A1 (de) | Zahnzement | |
DE69108022T3 (de) | Arzneimittel. | |
DE3402878A1 (de) | Arzneimittel und die verwendung schwerloeslicher calcium- und/oder magnesiumverbindungen als arzneimittel | |
DE2013039A1 (de) | Arzneimitteltablette zur oralen Verabreichung | |
DE3408085A1 (de) | Pharmazeutische praeparate mit gleichbleibenden elutionseigenschaften | |
DE2205272A1 (fr) | ||
EP0641200B1 (fr) | Compositions d'acide 2-arylpropionique et leur procede de preparation | |
EP0334167A1 (fr) | Médicament solide comprenant du Gallopamil | |
DE2126533A1 (de) | Verfahren zur Herstellung pharma zeutischer Zubereitungen | |
DE2013040A1 (de) | Arzneimitteltablette zur oralen Verabreichung | |
DE19912436A1 (de) | Ibuprofen-Lösung | |
DE2416216A1 (de) | Pharmazeutische zusammensetzung, verfahren zu deren herstellung und verwendung eines vehiculums dafuer | |
DE3208505C2 (fr) | ||
US2715622A (en) | Anthelmintic dye salts | |
DE2950832C2 (de) | Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid | |
DE68902755T2 (de) | Antineoplastische formulierungen. | |
DE4109508C1 (en) | 2-phenyl-1,2-benz:iso:selenazol-3(2H)-1-one - used for treating diabetes and diseases caused by inflammation of islet cells | |
DE69208913T2 (de) | 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung | |
DE2556001C3 (de) | Spritzfertige injizierbare Lösungen mit einem Gehalt an Alkalicanrenoat |